All News about Teva Pharmaceutical Industries ADR
4 Analysts Have This to Say About Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Teva Finalizes Nationwide Opioid Settlement Terms
November 22, 2022
Via Business Wire
Via Benzinga
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
November 10, 2022
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|